Rapport Therapeutics, Inc.
RAPP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002012593
In the last 90 days, Rapport Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $2.13B in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Rapport Therapeutics, Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Of which not filed for Q2 2025 | Q2 2025 | Change |
|---|---|---|---|---|
| Holders | 77 | 1 | 82 | +6 |
| Shares | 38.1M | 15 | 38.5M | +392.3K (+1.0%) |
| Value | $382.3M | $150 | $437.9M | +$55.6M (+14.5%) |
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (15)
Institutions that held Rapport Therapeutics, Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Baker Bros. Advisors LP | 550,090 | $6.25M | 0.06% |
| Affinity Asset Advisors, LLC | 199,643 | $2.27M | 0.34% |
| Sectoral Asset Management Inc | 179,860 | $2.05M | 1.35% |
| Driehaus Capital Management LLC | 131,340 | $1.49M | 0.01% |
| AQR Capital Management LLC | 16,972 | $193.0K | 0.00% |
| Renaissance Technologies LLC | 15,600 | $177.4K | 0.00% |
| Intech Investment Management LLC | 11,462 | $130.3K | 0.00% |
| Kennedy Capital Management, Inc. | 11,230 | $127.7K | 0.00% |
| Creative Planning | 10,602 | $120.5K | 0.00% |
| Nisa Investment Advisors, LLC | 1,353 | $15.4K | 0.00% |
| Parallel Advisors, LLC | 50 | $569 | 0.00% |
| Rise Advisors, LLC | 50 | $569 | 0.00% |
| Essential Partners LLC | 31 | $352 | 0.00% |
| SBI Securities Co., Ltd. | 23 | $262 | 0.00% |
| IFP Advisors, Inc | 3 | $34 | 0.00% |
Sold out (9)
Institutions that held Rapport Therapeutics, Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Citadel Advisors LLC | 249,414 | $2.50M |
| Swiss National Bank | 31,900 | $320.0K |
| XTX Topco Ltd | 15,442 | $154.9K |
| Jump Financial, LLC | 13,760 | $138.0K |
| Two Sigma Advisers, LP | 12,000 | $120.4K |
| Corebridge Financial, Inc. | 8,271 | $83.0K |
| KLP Kapitalforvaltning AS | 1,900 | $19.1K |
| US Bancorp | 144 | $1.44K |
| Allworth Financial LP | 15 | $167 |
Not filed for Q2 2025 yet (1)
Institutions that held Rapport Therapeutics, Inc. at the end of Q1 2025 and haven't filed a 13F for Q2 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Lindbrook Capital, LLC | 15 | $150 |